REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
2016 · The American Journal of Human Genetics · 2,867 citations
https://doi.org/10.1016/j.ajhg.2016.08.016
J
John D. Carpten
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
726
Papers
30.0K
Citations
74
h-index
210
i10-index
John D. Carpten is an academic researcher from University of Southern California. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Prostate Cancer Treatment and Research & Multiple Myeloma Research and Treatments. The author has an h-index of 74, co-authored 618 publications.
ORCID: 0000-0002-6862-2821Papers by this author
worksA transforming mutation in the pleckstrin homology domain of AKT1 in cancer
2007 · Nature · 1,272 citations
https://doi.org/10.1038/nature05933
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
2002 · Nature Genetics · 742 citations
https://doi.org/10.1038/ng1048
Germline Mutations in <i>HOXB13</i> and Prostate-Cancer Risk
2012 · New England Journal of Medicine · 656 citations
https://doi.org/10.1056/nejmoa1110000
Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2012 · Molecular Cancer Therapeutics · 224 citations
https://doi.org/10.1158/1535-7163.mct-12-0781
Integrated genomic analyses reveal frequent <i>TERT</i> aberrations in acral melanoma
2017 · Genome Research · 140 citations
https://doi.org/10.1101/gr.213348.116
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat